PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.52
ESG score below 80% of ADAP's 77.35. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
60.80
Environmental score below 80% of ADAP's 90.74. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
59.46
Social score 80-90% of ADAP's 71.70. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
58.31
Governance score 80-90% of ADAP's 69.60. Walter Schloss would scrutinize management accountability and board independence.